UBS Group’s NKGen Biotech, Inc. Common Stock NKGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-763
| Closed | -$500 | – | 9479 |
|
|
2024
Q4 | $500 | Sell |
763
-13,883
| -95% | -$9.1K | ﹤0.01% | 8199 |
|
|
2024
Q3 | $5.54K | Sell |
14,646
-29,171
| -67% | -$11K | ﹤0.01% | 6835 |
|
|
2024
Q2 | $55.6K | Buy |
43,817
+32,728
| +295% | +$41.6K | ﹤0.01% | 5467 |
|
|
2024
Q1 | $21K | Buy |
+11,089
| New | +$21K | ﹤0.01% | 5741 |
|
|
2023
Q2 | – | Sell |
-590
| Closed | -$5.98K | – | 8574 |
|
|
2023
Q1 | $5.98K | Sell |
590
-1,150
| -66% | -$11.7K | ﹤0.01% | 6873 |
|
|
2022
Q4 | $17.3K | Hold |
1,740
| – | – | ﹤0.01% | 6661 |
|
|
2022
Q3 | $17K | Buy |
+1,740
| New | +$17K | ﹤0.01% | 6533 |
|